Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DIVA test discovered to detect Johne's disease in goats
"This will support the use of vaccines as part of MAP control programs" - Professor Cath Rees.

Actiphage can differentiate between vaccinated and infected animals.

A new diagnostic test has shown potential to differentiate between vaccinated and infected animals with Johne's disease.

Previously, vaccination of livestock against Johne's disease, an infectious wasting condition affecting ruminants, has been hindered because there is no diagnostic test that can differentiate between vaccinated animals, and those with the disease (DIVA test). 

Researchers have discovered that the Actiphage blood test can differentiate between goats that are naturally infected with Johne's disease, and those with vaccinations. 

This discovery suggests potential for a vaccination programme to protect ruminants from the usually fatal disease. While previous tests to detect infection in vaccinated goats did not work, Actiphage detects live bacteria in a milk or blood sample. Because of this, the test is not affected by vaccination status. 

Professor Cath Rees, from the University of Nottingham, said: “We have now shown that Actiphage is compatible with a range of different methods for purifying white blood cells, demonstrating the versatility of our test and opening up a number of new applications.”

“This study provides evidence that Actiphage can also be used as a DIVA test, allowing us to differentiate between naturally infected and vaccinated animals; this will support the use of vaccines as part of MAP (Mycobacterium avium subspecies paratuberculosis) control programs.”

 

Image (C) PBD Biotech

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.